EA200971137A1 - Прямое растворение доцетаксела в растворителе в полисорбате 80 - Google Patents

Прямое растворение доцетаксела в растворителе в полисорбате 80

Info

Publication number
EA200971137A1
EA200971137A1 EA200971137A EA200971137A EA200971137A1 EA 200971137 A1 EA200971137 A1 EA 200971137A1 EA 200971137 A EA200971137 A EA 200971137A EA 200971137 A EA200971137 A EA 200971137A EA 200971137 A1 EA200971137 A1 EA 200971137A1
Authority
EA
Eurasian Patent Office
Prior art keywords
solvent
docetaxel
polysorbate
direct dissolution
dissolution
Prior art date
Application number
EA200971137A
Other languages
English (en)
Inventor
Жан-Рене Отелен
Эрик Дидье
Эли Фук
Мостафа Накаш
Original Assignee
Авентис Фарма С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39048780&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA200971137(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Авентис Фарма С.А. filed Critical Авентис Фарма С.А.
Publication of EA200971137A1 publication Critical patent/EA200971137A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Abstract

Изобретение относится к растворению доцетаксела в органическом растворителе, его смешиванию с полисорбатом 80 и выпариванию растворителя.
EA200971137A 2007-06-08 2008-06-06 Прямое растворение доцетаксела в растворителе в полисорбате 80 EA200971137A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0704095A FR2917088B1 (fr) 2007-06-08 2007-06-08 Dissolution directe du docetaxel dans un solvant dans le polysorbate 80
PCT/FR2008/000766 WO2009004188A2 (fr) 2007-06-08 2008-06-06 Dissolution directe du docetaxel dans un solvant dans le poly sorbate 80

Publications (1)

Publication Number Publication Date
EA200971137A1 true EA200971137A1 (ru) 2010-04-30

Family

ID=39048780

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200971137A EA200971137A1 (ru) 2007-06-08 2008-06-06 Прямое растворение доцетаксела в растворителе в полисорбате 80

Country Status (32)

Country Link
US (1) US20100197776A1 (ru)
EP (1) EP2155189A2 (ru)
JP (1) JP2010529094A (ru)
KR (1) KR20100022033A (ru)
CN (2) CN101677986A (ru)
AR (1) AR066889A1 (ru)
AU (1) AU2008270141A1 (ru)
BR (1) BRPI0812438A2 (ru)
CA (1) CA2689466A1 (ru)
CL (1) CL2008001650A1 (ru)
CO (1) CO6260063A2 (ru)
CR (1) CR11144A (ru)
DO (1) DOP2009000249A (ru)
EA (1) EA200971137A1 (ru)
EC (1) ECSP099789A (ru)
FR (1) FR2917088B1 (ru)
GT (1) GT200900306A (ru)
HN (1) HN2009003363A (ru)
IL (1) IL202517A0 (ru)
MA (1) MA31671B1 (ru)
MX (1) MX2009013216A (ru)
MY (1) MY151417A (ru)
NI (1) NI200900209A (ru)
NZ (1) NZ581634A (ru)
PA (1) PA8783101A1 (ru)
SV (1) SV2009003428A (ru)
TN (1) TN2009000396A1 (ru)
TW (1) TW200916095A (ru)
UA (1) UA99828C2 (ru)
UY (1) UY31129A1 (ru)
WO (1) WO2009004188A2 (ru)
ZA (1) ZA200908662B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101752944B1 (ko) 2010-05-03 2017-07-03 테이코쿠 팔마 유에스에이, 인코포레이티드 비수성의 탁산 프로에멀젼 제제, 및 그의 제조 및 사용 방법
JO3685B1 (ar) * 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2678833B1 (fr) * 1991-07-08 1995-04-07 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes.
US6040330A (en) * 1999-01-08 2000-03-21 Bionumerik Pharmaceuticals, Inc. Pharmaceutical formulations of taxanes
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
US20020041898A1 (en) * 2000-01-05 2002-04-11 Unger Evan C. Novel targeted delivery systems for bioactive agents
US6838569B2 (en) * 2002-12-16 2005-01-04 Dabur India Limited Process for preparation of paclitaxel trihydrate and docetaxel trihydrate
WO2006057429A1 (ja) * 2004-11-24 2006-06-01 Nanocarrier Co., Ltd. ブロックコポリマーのモーフォロジ－の変化方法
BRPI0600194A (pt) * 2006-01-30 2007-10-23 Quiral Quimica Do Brasil S A composições farmacêuticas contendo docetaxel e um inibidor de degradação e processo de obtenção das mesmas

Also Published As

Publication number Publication date
BRPI0812438A2 (pt) 2014-12-02
FR2917088B1 (fr) 2009-09-04
CN101677986A (zh) 2010-03-24
PA8783101A1 (es) 2009-01-23
NZ581634A (en) 2012-05-25
CR11144A (es) 2010-03-23
ECSP099789A (es) 2010-01-29
CO6260063A2 (es) 2011-03-22
CL2008001650A1 (es) 2009-10-23
MY151417A (en) 2014-05-30
MA31671B1 (fr) 2010-09-01
FR2917088A1 (fr) 2008-12-12
US20100197776A1 (en) 2010-08-05
UY31129A1 (es) 2009-01-30
CN102908309A (zh) 2013-02-06
ZA200908662B (en) 2011-04-28
TW200916095A (en) 2009-04-16
TN2009000396A1 (fr) 2010-12-31
MX2009013216A (es) 2010-01-25
KR20100022033A (ko) 2010-02-26
GT200900306A (es) 2011-06-17
EP2155189A2 (fr) 2010-02-24
IL202517A0 (en) 2010-06-30
AR066889A1 (es) 2009-09-16
JP2010529094A (ja) 2010-08-26
UA99828C2 (ru) 2012-10-10
DOP2009000249A (es) 2009-11-30
HN2009003363A (es) 2013-09-18
AU2008270141A1 (en) 2009-01-08
CA2689466A1 (fr) 2009-01-08
WO2009004188A2 (fr) 2009-01-08
SV2009003428A (es) 2010-02-05
NI200900209A (es) 2010-10-04
WO2009004188A3 (fr) 2009-03-26

Similar Documents

Publication Publication Date Title
CL2007000311A1 (es) Compuestos derivados de cromen-2-ona; composicion farmaceutica que los comprende;y su uso en el trastamiento de un trastorno proliferativos como es el cancer.
ATE538157T1 (de) Indenofluoren- und thiophen-copolymere
DE502006004472D1 (de) Organische elektrolumineszenzvorrichtungen
CL2008002042A1 (es) Compuestos derivados de heterociclos nitrogenados enlazados; y su uso en el tratamiento de la diabetes y desordenes metabolicos.
TW200740956A (en) Organic electroluminescent devices
CL2008001076A1 (es) Compuestos derivados de sulfonamida; composicion farmaceutica; y uso en el tratamiento del cancer.
EA200802184A1 (ru) Фармацевтические композиции с ингибиторами dpp iv
CL2011000846A1 (es) Compuestos heterociclicos sustituidos; composicion farmaceutica; y su uso para el tratamiento de la hepatitis c.
CR20110100A (es) Nuevos derivados de sulfamida sustituida
CL2009000119A1 (es) Compuestos derivados de amino-bencimidazoles sustituidos; composicion farmaceutica; y su uso en el tratamiento del alzheimer.
MX280211B (es) Polimero, un metodo para producir el polimero y una mezcla de cemento que utiliza el mismo.
BRPI0819785A2 (pt) Processo isento de solvente orgânico, composição, e , uso de uma composição
CL2007003672A1 (es) Compuestos derivados de heteroaril-pirrolidinil-cetona y heteroaril-piperidinil-cetona; composicion farmaceutica; y uso en el tratamiento de la depresion y ansiedad.
CL2011000073A1 (es) Uso de compuestos derivados de pirimidil-amino-benzamida; composicion farmaceutica ; y su uso en el tratamiento de fibrosis hepatica y fibrosis pulmonar.
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
CL2009000665A1 (es) Compuestos derivados de pirrolidinilo; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la ansiedad, depresion o ambas.
EA200900780A1 (ru) Аналоги эпотилона, модифицированные в положениях c12-c13, как противораковые лекарственные средства
EA200971137A1 (ru) Прямое растворение доцетаксела в растворителе в полисорбате 80
CL2008000092A1 (es) Compuestos derivados de 3-cianopiridina, inhibidores del receptor p2y12; composicion farmaceutica que comprende a dichos compustos; y su uso en el tratamiento del transtorno de la agregacion plaquetaria.
CL2008001322A1 (es) Compuestos derivados de triazolil-aminopirimidina, sustituida con heterociclos; composicion farmaceutica; y uso en el tratamiento del cancer.
CL2009000317A1 (es) Compuestos derivados de 3-alquil-piperazina sustituida; composicion farmaceutica; y su uso en el tratamiento de la depresion y ansiedad.
CL2012000355A1 (es) Compuestos derivados de 4-amino-butenamida; composicion farmaceutica; y uso en el tratamiento de la epoc.
BRPI0919176A2 (pt) composição farmacêutica com intensidade iônica relativamente baixa.
CL2013000210A1 (es) Compuestos derivados de tiofeno 2,3,5 trisustituidos; composición farmacéutica; combinación farmacéutica; y su uso para el tratamiento de un trastorno o enfermedad en un sujeto causado o asociado con una infeccion por vhc, tales como cirrosis hepatica, carcinoma hepatocelular, entre otras.
TH80722B (th) มีด